サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1641804

酵母エキスの世界市場：タイプ別、用途別、形態別 - 機会分析と産業予測（2024年～2035年）

Yeast Extract Market By Type (Yeastolate, Yeast Extracts, Active Dry Yeast), By Application (Pharmaceuticals, Biotechnology), By Form (Liquid, Dry): Global Opportunity Analysis and Industry Forecast, 2024-2035

出版日
ページ情報
英文 250 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
酵母エキスの世界市場：タイプ別、用途別、形態別 - 機会分析と産業予測（2024年～2035年）
出版日: 2024年12月01日
発行: Allied Market Research
ページ情報: 英文 250 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

酵母エキス市場

Yeast Extract Market-IMG1

世界の酵母エキス市場は、2023年には4億4,090万米ドルと評価され、2024年から2035年までのCAGRは7.5％を記録し、2035年には10億3,830万米ドルに達すると予測されています。

酵母エキスは、酵母、一般的にはサッカロマイセス・セレビシエ（Saccharomyces cerevisiae）の細胞内容物から得られる天然成分です。酵母細胞は自己分解や酵素処理などのプロセスによって分解され、可溶性成分が濃縮されてペースト状、粉末状、液状になります。エキスは、ビタミン、タンパク質、アミノ酸、β-グルカン、ヌクレオチドを含むため、豊富な栄養プロファイルを示します。

酵母エキスの豊富な栄養プロファイルにより、酵母エキスはバイオ医薬品セクターにおいて様々な医薬品の生産に不可欠な成分となっています。したがって、バイオ医薬品セクターの拡大が酵母エキス市場の重要な促進要因となっています。さらに、消費者のクリーンラベル製品への傾斜は、酵母エキスが天然の風味増強剤として機能するため、食品・飲料への人工香料の添加を制限し、市場の成長を増強しています。その顕著な栄養価により、家畜、家禽、水生生物の飼料におけるサプリメントとしての酵母エキスの使用は顕著な動向となっています。酵母エキスは家畜の飼料転換率を向上させ、免疫力を高めます。

しかし、酵母エキスの大規模生産は、発酵プロセス用の特殊な設備と良質の原料を必要とするため、高価なプロセスです。このため、価格に敏感な分野では酵母エキスの購入が制限され、市場開拓を抑制しています。それとは反対に、酵母エキスの発酵は廃棄物削減と持続可能な開拓アプローチに合致するため、循環経済に関する意識の高まりは市場に有利な機会をもたらすと予測されます。酵母エキスは醸造や製パン産業の製品別から容易に入手できるため、持続可能性を促進し、環境への影響を低減します。国連の報告書によると、循環型経済アプローチを採用することで、2050年までに都市固形廃棄物の量を年間45億トン以上から20億トン以下に削減できると予想されています。したがって、産業製品別による酵母エキスの生産は、その全体的な価格を下げ、市場に新たな道を開くと予測されます。

セグメント別レビュー

酵母エキス市場は、タイプ、用途、形態、地域に区分されます。タイプ別では、市場はイーストレート、酵母エキス、活性ドライイーストに分けられます。用途別では、医薬品とバイオテクノロジーに二分されます。さらに、医薬品セグメントは、ワクチン生産、プロバイオティクス、抗生物質生産、バイオ医薬品に分けられます。バイオテクノロジー分野は、細胞培養培地と酵素生産に分けられます。形態別では、市場は液体と乾燥に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（フランス、ドイツ、イタリア、スペイン、英国、ロシア、その他欧州地域）、アジア太平洋地域（中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域）、ラテンアメリカ・中東・アフリカ（ブラジル、南アフリカ、サウジアラビア、UAE、アルゼンチン、その他ラテンアメリカ・中東・アフリカ）で分析されます。

主な調査結果

タイプ別では、活性ドライイーストセグメントが2023年の市場を独占しました。

用途別では、医薬品セグメントが2023年の市場で注目すべき地位を獲得しました。

形態別では、ドライセグメントが2023年に最高株主となった。

地域別では、欧州が2023年に最も高い収益を上げました。

利害関係者にとっての主なメリット

当レポートでは、2023年から2035年にかけての酵母エキス市場分析の市場セグメント、現在の動向、推定・動向分析、ダイナミクスを定量的に分析し、優勢な酵母エキス市場機会を特定します。

市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。

ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるように、バイヤーとサプライヤーの潜在力を強調します。

酵母エキス市場のセグメンテーションの詳細な分析により、市場機会を決定します。

各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。

市場企業のポジショニングはベンチマーキングを容易にし、市場企業の現在のポジションを明確に理解することができます。

本レポートには、地域および世界の酵母エキス市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートで可能なカスタマイズ

  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析 - 市場規模と予測

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • バイオ医薬品産業の成長
      • バイオテクノロジーの進歩
      • バイオプロセスにおける歩留まりと品質の向上
    • 抑制要因
      • 高い生産コスト
      • 規制上のハードル
    • 機会
      • 新興市場での拡大
      • 個別化医療への応用

第4章 酵母エキス市場：タイプ別

  • 概要
  • イーストレート
  • 酵母エキス
  • 活性ドライイースト

第5章 酵母エキス市場：用途別

  • 概要
  • 医薬品
    • 医薬品酵母エキス市場：サブタイプ別
  • バイオテクノロジー
    • バイオテクノロジー酵母エキス市場：サブタイプ別

第6章 酵母エキス市場：形態別

  • 概要
  • 液体
  • 乾燥

第7章 酵母エキス市場：地域別

  • 概要
  • 北米
    • 北米の医薬品酵母エキス市場：サブタイプ別
    • 北米のバイオテクノロジー用酵母エキス市場：サブタイプ別
    • 米国
    • 米国の医薬品酵母エキス市場：サブタイプ別
    • 米国のバイオテクノロジー酵母エキス市場：サブタイプ別
    • カナダ
    • カナダの医薬品酵母エキス市場：サブタイプ別
    • カナダのバイオテクノロジー酵母エキス市場：サブタイプ別
    • メキシコ
    • メキシコの医薬品酵母エキス市場：サブタイプ別
    • メキシコのバイオテクノロジー酵母エキス市場：サブタイプ別
  • 欧州
    • 欧州の医薬品酵母エキス市場：サブタイプ別
    • 欧州のバイオテクノロジー酵母エキス市場：サブタイプ別
    • フランス
    • フランスの医薬品酵母エキス市場：サブタイプ別
    • フランスのバイオテクノロジー酵母エキス市場：サブタイプ別
    • ドイツ
    • ドイツの医薬品酵母エキス市場：サブタイプ別
    • ドイツのバイオテクノロジー酵母エキス市場：サブタイプ別
    • イタリア
    • イタリアの医薬品酵母エキス市場：サブタイプ別
    • イタリアのバイオテクノロジー酵母エキス市場：サブタイプ別
    • スペイン
    • スペインの医薬品酵母エキス市場：サブタイプ別
    • スペインのバイオテクノロジー酵母エキス市場：サブタイプ別
    • 英国
    • 英国の医薬品酵母エキス市場：サブタイプ別
    • 英国のバイオテクノロジー酵母エキス市場：サブタイプ別
    • ロシア
    • ロシアの医薬品酵母エキス市場：サブタイプ別
    • ロシアのバイオテクノロジー用酵母エキス市場：サブタイプ別
    • その他
    • その他欧州の医薬品酵母エキス市場：サブタイプ別
    • その他欧州のバイオテクノロジー酵母エキス市場：サブタイプ別
  • アジア太平洋
    • アジア太平洋の医薬品酵母エキス市場：サブタイプ別
    • アジア太平洋のバイオテクノロジー酵母エキス市場：サブタイプ別
    • 中国
    • 中国の医薬品酵母エキス市場：サブタイプ別
    • 中国のバイオテクノロジー酵母エキス市場：サブタイプ別
    • 日本
    • 日本の医薬品酵母エキス市場：サブタイプ別
    • 日本のバイオテクノロジー酵母エキス市場：サブタイプ別
    • インド
    • インドの医薬品酵母エキス市場：サブタイプ別
    • インドのバイオテクノロジー酵母エキス市場：サブタイプ別
    • 韓国
    • 韓国の医薬品酵母エキス市場：サブタイプ別
    • 韓国のバイオテクノロジー酵母エキス市場：サブタイプ別
    • オーストラリア
    • オーストラリアの医薬品酵母エキス市場：サブタイプ別
    • オーストラリアのバイオテクノロジー用酵母エキス市場：サブタイプ別
    • その他
    • その他アジア太平洋の医薬品酵母エキス市場：サブタイプ別
    • その他アジア太平洋のバイオテクノロジー酵母エキス市場：サブタイプ別
  • ラテンアメリカ・中東・アフリカ（LAMEA）
    • LAMEAの医薬品酵母エキス市場：サブタイプ別
    • LAMEAのバイオテクノロジー用酵母エキス市場：サブタイプ別
    • ブラジル
    • ブラジルの医薬品酵母エキス市場：サブタイプ別
    • ブラジルのバイオテクノロジー酵母エキス市場：サブタイプ別
    • 南アフリカ
    • 南アフリカの医薬品酵母エキスの市場：サブタイプ別
    • 南アフリカのバイオテクノロジー酵母エキス市場：サブタイプ別
    • サウジアラビア
    • サウジアラビアの医薬品酵母エキス市場：サブタイプ別
    • サウジアラビアのバイオテクノロジー酵母エキス市場：サブタイプ別
    • アラブ首長国連邦（UAE）
    • UAEの医薬品酵母エキス市場：サブタイプ別
    • UAEのバイオテクノロジー酵母エキス市場：サブタイプ別
    • アルゼンチン
    • アルゼンチンの医薬品酵母エキス市場：サブタイプ別
    • アルゼンチンのバイオテクノロジー酵母エキス市場：サブタイプ別
    • その他LAMEA
    • その他LAMEAの医薬品酵母エキス市場：サブタイプ別
    • その他LAMEAのバイオテクノロジー酵母エキス市場：サブタイプ別

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要企業10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • LESAFFRE GROUP
  • Kerry Group
  • Lallemand Inc.
  • AngelYeast Co., Ltd.
  • Associated British Foods PLC
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC.
  • Merck KGaA
  • CELLSECO LTD.
  • FUJIFILM Irvine Scientific
  • Nu-Tek BioSciences
目次
Product Code: A06568

Yeast Extract Market

Yeast Extract Market - IMG1

The global yeast extract market was valued at $440.9 million in 2023 and is projected to reach $1,038.3 million by 2035, registering a CAGR of 7.5% from 2024 to 2035.

Yeast extract is a natural component derived from the cellular content of yeasts, generally Saccharomyces cerevisiae. The yeast cells are broken down through processes such as autolysis or enzymatic treatment and their soluble components are concentrated into a paste, powder, or liquid form. The extract exhibits a rich nutritional profile as it comprises vitamins, proteins, amino acids, beta-glucans, and nucleotides.

The rich nutritional profile of yeast extract has made it a critical ingredient in the biopharmaceutical sector for the production of different medications. Therefore, the expansion of the biopharmaceutical sector is a significant driver of the yeast extract market. In addition, the inclination of consumers toward clean-label products is augmenting the market growth as yeast extract serves as a natural flavor enhancer, thus limiting the addition of artificial flavors in food & beverages. Due to its remarkable nutritional value, the usage of yeast extract as a supplement in the feed of livestock, poultry, and aquatic organisms has become a prominent trend. The extract helps to improve the feed conversion ratios of animals and enhances their immunity.

However, large-scale production of yeast extract is an expensive process as it requires specialized equipment for fermentation processes and good quality raw materials. This limits the purchase of the extract in price-sensitive sectors, hence restraining the market development. On the contrary, rise in awareness regarding circular economy is projected to present lucrative opportunities for the market as the fermentation of yeast extract aligns with the waste reduction and sustainable development approaches. Yeast extract is easily attainable from the byproducts of the brewing or baking industry, hence promoting sustainability and reducing environmental impact. According to a report by the United Nations, the adoption of circular economy approach is anticipated to reduce the volume of municipal solid waste from more than 4.5 billion tons a year to less than 2 billion tons by 2050. Therefore, the production of yeast extract by industrial byproducts is projected to reduce its overall prices and open new avenues for the market.

Segment Review

The yeast extract market is segmented into type, application, form, and region. By type, the market is divided into yeastolate, yeast extracts, and active dry yeast. According to application, it is bifurcated into pharmaceuticals and biotechnology. Further, the pharmaceuticals segment is divided into vaccine production, probiotics, antibiotic production, and biopharmaceuticals. The biotechnology segment is segregated into cell culture media and enzyme production. As per form, the market is classified into liquid and dry. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (France, Germany, Italy, Spain, UK, Russia, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Argentina, and rest of LAMEA).

Key Findings

By type, the active dry yeast segment dominated the market in 2023.

According to application, the pharmaceuticals segment acquired a notable stake in the market in 2023.

As per form, the dry segment was the highest shareholder in 2023.

Region wise, Europe was the highest revenue generator in 2023.

Competition Analysis

The major players in the yeast extract market include AngelYeast Co., Ltd., Associated British Foods PLC, CELLSECO LTD., FUJIFILM Irvine Scientific, Kerry Group, Lallemand Inc., LESAFFRE GROUP, Merck KGaA, Nu-Tek BioSciences, Thermo Fisher Scientific Inc., and VWR International, LLC. These major players have adopted various key development strategies such as acquisition, agreement, collaboration, joint venture, partnership, and product launch to strengthen their foothold in the competitive market.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the yeast extract market analysis from 2023 to 2035 to identify the prevailing yeast extract market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the yeast extract market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global yeast extract market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast

Key Market Segments

By Form

  • Liquid
  • Dry

By Type

  • Yeastolate
  • Yeast Extracts
  • Active Dry Yeast

By Application

  • Pharmaceuticals
    • Sub-type
    • Vaccine Production
    • Probiotics
    • Antibiotic Production
    • Biopharmaceuticals
  • Biotechnology
    • Sub-type
    • Cell Culture Media
    • Enzyme Production

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • UAE
    • Argentina
    • Rest of LAMEA

Key Market Players:

    • LESAFFRE GROUP
    • Lallemand Inc.
    • Associated British Foods PLC
    • CELLSECO LTD.
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Nu-Tek BioSciences
    • Kerry Group
    • VWR International, LLC.
    • FUJIFILM Irvine Scientific
    • AngelYeast Co., Ltd.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growing Biopharmaceutical Industry
      • 3.4.1.2. Advancements in Biotechnology
      • 3.4.1.3. Improved Yield and Quality in Bioprocessing
    • 3.4.2. Restraints
      • 3.4.2.1. High Production Cost
      • 3.4.2.2. Regulatory Hurdles
    • 3.4.3. Opportunities
      • 3.4.3.1. Expansion in Emerging Markets
      • 3.4.3.2. Application in Personalized Medicine

CHAPTER 4: YEAST EXTRACT MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Yeastolate
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Yeast Extracts
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Active Dry Yeast
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: YEAST EXTRACT MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Pharmaceuticals
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. Pharmaceuticals Yeast Extract Market by Sub-type
      • 5.2.4.1. Vaccine Production Market size and forecast, by region
      • 5.2.4.2. Vaccine Production Market size and forecast, by country
      • 5.2.4.3. Probiotics Market size and forecast, by region
      • 5.2.4.4. Probiotics Market size and forecast, by country
      • 5.2.4.5. Antibiotic Production Market size and forecast, by region
      • 5.2.4.6. Antibiotic Production Market size and forecast, by country
      • 5.2.4.7. Biopharmaceuticals Market size and forecast, by region
      • 5.2.4.8. Biopharmaceuticals Market size and forecast, by country
  • 5.3. Biotechnology
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Biotechnology Yeast Extract Market by Sub-type
      • 5.3.4.1. Cell Culture Media Market size and forecast, by region
      • 5.3.4.2. Cell Culture Media Market size and forecast, by country
      • 5.3.4.3. Enzyme Production Market size and forecast, by region
      • 5.3.4.4. Enzyme Production Market size and forecast, by country

CHAPTER 6: YEAST EXTRACT MARKET, BY FORM

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Liquid
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Dry
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: YEAST EXTRACT MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
      • 7.2.3.1. North America Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.3.2. North America Biotechnology Yeast Extract Market by Sub-type
    • 7.2.4. Market size and forecast, by Form
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.2.1. U.S. Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.5.1.2.2. U.S. Biotechnology Yeast Extract Market by Sub-type
      • 7.2.5.1.3. Market size and forecast, by Form
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.2.1. Canada Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.5.2.2.2. Canada Biotechnology Yeast Extract Market by Sub-type
      • 7.2.5.2.3. Market size and forecast, by Form
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.2.1. Mexico Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.5.3.2.2. Mexico Biotechnology Yeast Extract Market by Sub-type
      • 7.2.5.3.3. Market size and forecast, by Form
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
      • 7.3.3.1. Europe Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.3.2. Europe Biotechnology Yeast Extract Market by Sub-type
    • 7.3.4. Market size and forecast, by Form
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. France
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.2.1. France Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.1.2.2. France Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.1.3. Market size and forecast, by Form
      • 7.3.5.2. Germany
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.2.1. Germany Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.2.2.2. Germany Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.2.3. Market size and forecast, by Form
      • 7.3.5.3. Italy
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.2.1. Italy Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.3.2.2. Italy Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.3.3. Market size and forecast, by Form
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.2.1. Spain Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.4.2.2. Spain Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.4.3. Market size and forecast, by Form
      • 7.3.5.5. UK
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.2.1. UK Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.5.2.2. UK Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.5.3. Market size and forecast, by Form
      • 7.3.5.6. Russia
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.2.1. Russia Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.6.2.2. Russia Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.6.3. Market size and forecast, by Form
      • 7.3.5.7. Rest of Europe
      • 7.3.5.7.1. Market size and forecast, by Type
      • 7.3.5.7.2. Market size and forecast, by Application
      • 7.3.5.7.2.1. Rest of Europe Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.7.2.2. Rest of Europe Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.7.3. Market size and forecast, by Form
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
      • 7.4.3.1. Asia-Pacific Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.3.2. Asia-Pacific Biotechnology Yeast Extract Market by Sub-type
    • 7.4.4. Market size and forecast, by Form
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.2.1. China Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.1.2.2. China Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.1.3. Market size and forecast, by Form
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.2.1. Japan Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.2.2.2. Japan Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.2.3. Market size and forecast, by Form
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.2.1. India Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.3.2.2. India Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.3.3. Market size and forecast, by Form
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.2.1. South Korea Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.4.2.2. South Korea Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.4.3. Market size and forecast, by Form
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.2.1. Australia Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.5.2.2. Australia Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.5.3. Market size and forecast, by Form
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.2.1. Rest of Asia-Pacific Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.6.2.2. Rest of Asia-Pacific Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.6.3. Market size and forecast, by Form
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
      • 7.5.3.1. LAMEA Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.3.2. LAMEA Biotechnology Yeast Extract Market by Sub-type
    • 7.5.4. Market size and forecast, by Form
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.2.1. Brazil Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.1.2.2. Brazil Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.1.3. Market size and forecast, by Form
      • 7.5.5.2. South Africa,
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.2.1. South Africa, Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.2.2.2. South Africa, Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.2.3. Market size and forecast, by Form
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.2.1. Saudi Arabia Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.3.2.2. Saudi Arabia Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.3.3. Market size and forecast, by Form
      • 7.5.5.4. UAE
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.2.1. UAE Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.4.2.2. UAE Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.4.3. Market size and forecast, by Form
      • 7.5.5.5. Argentina
      • 7.5.5.5.1. Market size and forecast, by Type
      • 7.5.5.5.2. Market size and forecast, by Application
      • 7.5.5.5.2.1. Argentina Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.5.2.2. Argentina Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.5.3. Market size and forecast, by Form
      • 7.5.5.6. Rest of LAMEA
      • 7.5.5.6.1. Market size and forecast, by Type
      • 7.5.5.6.2. Market size and forecast, by Application
      • 7.5.5.6.2.1. Rest of LAMEA Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.6.2.2. Rest of LAMEA Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.6.3. Market size and forecast, by Form

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. LESAFFRE GROUP
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Key strategic moves and developments
  • 9.2. Kerry Group
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Lallemand Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. AngelYeast Co., Ltd.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Key strategic moves and developments
  • 9.5. Associated British Foods PLC
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Thermo Fisher Scientific Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
  • 9.7. VWR International, LLC.
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. Merck KGaA
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. CELLSECO LTD.
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. FUJIFILM Irvine Scientific
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
  • 9.11. Nu-Tek BioSciences
    • 9.11.1. Company overview
    • 9.11.2. Key executives
    • 9.11.3. Company snapshot
    • 9.11.4. Operating business segments
    • 9.11.5. Product portfolio